[Acute heart failure and early development of left ventricular dysfunction in patients with ST segment elevation

J Parenica1, P Kala, J Jarkovský

  • 1Interní kardiologická klinika Lékarské fakulty MU a FN Brno. jiri.parenica@atlas.cz

Vnitrni Lekarstvi
|March 1, 2011
PubMed

Insights

Acute heart failure (AHF) affects one-third of ST-elevation myocardial infarction (STEMI) patients, increasing mortality risk. Higher blood sugar, heart rate, anterior MI, and age are key predictors of AHF and left ventricular dysfunction.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Biomedical Science

Context:

  • Acute heart failure (AHF) significantly worsens prognosis in patients experiencing ST-elevation myocardial infarction (STEMI).
  • Early identification of factors predicting AHF and left ventricular dysfunction is crucial for improving patient outcomes.
  • This study prospectively evaluates patients with STEMI undergoing primary percutaneous coronary intervention (PCI).

Purpose:

  • To identify independent predictors of acute heart failure (AHF) in STEMI patients.
  • To determine factors associated with early left ventricular dysfunction following STEMI.
  • To analyze the relationship between baseline patient characteristics, biomarkers, and AHF development.

Summary:

  • A cohort of 593 STEMI patients (164 with AHF) treated with primary PCI was studied.
  • Biomarkers (BNP, NT-ProBNP), echocardiography, and left ventricular angiography were utilized.
  • Independent predictors for AHF and left ventricular dysfunction included higher glucose levels, age, heart rate, and anterior wall MI; lower aortic pulse pressure was associated with reduced risk.

Impact:

  • AHF was observed in one-third of STEMI patients, with mortality risk escalating with failure severity.
  • Findings highlight the prognostic significance of AHF and identify key modifiable and non-modifiable risk factors.
  • Establishing cut-off values for LVEDP, dP/dt/P, glycaemia, and aortic pulse pressure aids in AHF risk stratification.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...